Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea | Business Wire
Official Sage Central Patient Support | Sage Therapeutics, Inc. Official Sage Central Patient Support | Sage Therapeutics Inc.
Fmr Increases Position in SAGE Therapeutics (SAGE)
SAGE Therapeutics, Inc. (NASD:SAGE) Seasonal Chart | Equity Clock
Sage Therapeutics' (SAGE) Highest Price: $192.33 (on 02-01-2018)